COMMISSION IMPLEMENTING REGULATION (EU) 2025/2074 | 32025R2074 — European Union law | Esheria

COMMISSION IMPLEMENTING REGULATION (EU) 2025/2074

The regulation grants B. Braun Medical AG a Union authorisation for the biocidal product family, subject to Annex I and Annex II conditions.

AI-assisted research synopsis — verify against the official legal text below.

Jurisdiction
European Union
Instrument
Regulation
Citation
32025R2074
Status
In force
Version
Undated source snapshot
Language
en
Official source
View official record ↗
biocidal products disinfectants market placement personal protective equipment product authorisation product instructions product labelling protective equipment storage and disposal storage and handling storage stability testing surface disinfection

Publicly available, excluded from search-engine indexing

This page remains available for direct access and API use, but this release emits noindex,follow for the following reason:

  • The record does not meet this release's canonical indexing criteria. (emergency-noindex)

Statute overview

About this statute

The regulation grants B. Braun Medical AG a Union authorisation for the biocidal product family, subject to Annex I and Annex II conditions. This provision sets use instructions and safety measures for professional users of the product, including PPE, storage, disposal, and maximum application limits. Professional users must use eye protection, follow the surface-treatment instructions, and dispose of contaminated packaging properly.